Aalto Bio Reagents Launches First Monoclonal Antibody Against SARS-CoV-2 Nucleocapsid Protein.
Seasoned Industry Veteran to Take Company Through Next Phase of Operations
The company supplied critical reagent to the HSE in April for C-19 testing
The Europe genetic testing market is poised to exhibit nearly 13% CAGR during 2020 to 2026 owing to presence of major market players and growing geriatric population in the region.
For development of the breakthrough MultiPath platform and culture-free, anti-microbial susceptibility tests
Commits to deliver platform to enable targeted treatment at the onset of infection
Two-day event highlights investment trends and opportunities in Life Sciences
New Senior VP of R&D and Regulatory Affairs will help guide product development and regulatory clearance.
Mako Medical partners with GoKart Kids and GoKart Transportation -- a new rideshare program that focuses on children and patients.
Mako Medical's innovation continues to propel its record-setting growth
Mako Medical Laboratories set a new healthcare record in 2018 -- becoming the first lab to ever win the Life Science award two times
Jun Kimura, MD Emeritus Professor of Neurology at the University of Iowa will be the keynote presenter at the annual symposium of Hands-On Diagnostics this coming September
Physical Therapists in private practice face unique challenges. Dr. Dimitrios Kostopoulos, co-founder of Hands-On Diagnostics, discusses the top 3 of them and reveals the secrets to conquer them.
A2iA Enters into Partnership with World-Leading Diagnostic Testing Organization to Modernize Operations within its Primary Business Unit
